VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis
Genovese, Mark C., van Vollenhoven, Ronald F., Pacheco-Tena, César, Zhang, Yanqiong, Kinnman, NilsVolume:
68
Language:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.39473
Date:
January, 2016
File:
PDF, 243 KB
english, 2016